Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

Cancer

Volumn 121, Issue 19, 2015, Pages 3491-3498

  Dupuy, Damian E ^a   Fernando, Hiran C ^b   Hillman, Shauna ^c   Ng, Thomas ^a   Tan, Angelina D ^c   Sharma, Amita ^d   Rilling, William S ^e   Hong, Kelvin ^f   Putnam, Joe B ^g  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ablation; elderly; non small cell lung cancer (NSCLC); radiofrequency ablation (RFA); stereotactic body radiotherapy (SBRT)

Indexed keywords

CARBON MONOXIDE; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSPNEA; FATALITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; HYPOXIA; LOCAL RECURRENCE FREE SURVIVAL; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REOPERATION; SURVIVAL TIME; TOTAL LUNG CAPACITY; TREATMENT RESPONSE; TUMOR VOLUME; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; CLINICAL TRIAL; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RADIOSURGERY; SURVIVAL ANALYSIS;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOSURGERY; SURVIVAL ANALYSIS;

EID: 84941941493     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29507     Document Type: Article

References (23)

1. American Lung Association. Lung cancer fact sheet. http://www.lung.org/lung-disease/lung-cancer/resources/facts-figures/lung-cancer-fact-sheet.html. Accessed December 2014.
2. Dupuy DE,. Treatment of medically inoperable non-small cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete? J Vasc Interv Radiol. 2013; 24: 1139-1145.
3. Ahmed M, Brace CL, Lee FT, Goldberg SN,. Principles of and advances in percutaneous ablation. Radiology. 2011; 258: 351-369.
4. Zemylak A, Moore WH, Bilfinger TV,. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 2010; 211: 68-72.
5. Ambrogi MC, Fanucchi O, Cioni R, et al., Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol. 2011; 6: 2044-2051.
6. Dupuy DE,. Image-guided thermal ablation of lung malignancies. Radiology. 2011; 260: 633-655.
7. Dupuy DE, DiPetrillo T, Gandi S, et al., Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006; 129: 738-745.
8. Timmerman R, Paulus R, Galvin J, et al., Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303: 1070-1076.
9. Mahler DA, Wells CK,. Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93: 580-586.
10. Yoo DJ, Dupuy DE, Hillman SL, et al., Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are posttreatment PET findings predictive of treatment outcome? AJR Am J Roentgenol. 2011; 197: 334-340.
11. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf. Accessed December 2014.
12. Dupuy DE, Zagoria R, Akerley W, Mayo-Smith W, Kavanagh P, Safran H,. Percutaneous RF ablation of malignancies in the lung. AJR Am J Roentgenol. 2000; 174: 57-59.
13. Lencioni R, Crocetti L, Cioni R, et al., Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicenter clinical trial (the RAPTURE study). Lancet Oncol. 2008; 9: 621-628.
14. Simon CJ, Dupuy DE, DiPetrillo TA, et al., Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007; 243: 268-275.
15. Rami-Porta R, Ball D, Crowley J, et al., The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2: 593-602.
16. Matsuo Y, Shibuya K, Nagata Y, et al., Prognostic factors in stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2009; 79: 1104-1111.
17. Lanuti M, Sharma A, Digumarthy SR, et al., Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137: 160-166.
18. Brace CL, Hinshaw JL, Laeseke PF, et al., Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009; 251: 705-711.
19. Crabtree T, Puri V, Timmerman R, et al., Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg. 2013; 145: 692-699.
20. Kwan SW, Mortell KE, Talenfeld AD, Brunner MC,. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Interv Radiol. 2014; 25: 1-9.
21. Kwan SW, Mortell KE, Hippe DS, Brunner MC,. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small cell lung cancer. J Vasc Interv Radiol. 2014; 25: 1558-1564.
22. Lee PC, Altorki NK,. Extent of resection for stage I lung cancer. In:, Pass HI, Carbone D, Johnson DH, Minna JD, Scagliotti GV, Turrissi AT, eds. Principles and Practice of Lung Cancer. 4th ed. New York, NY: Wolters Kluwer; 2010: 459-465.
23. Simone CB, Wildt B, Haas AR, Pope G, Rengan R, Hahn SM,. Stereotactic body radiation therapy for lung cancer. Chest. 2013; 143: 1784-1790.